Key result
Labetalol lowers vascular resistance and tone ~20% vs. propranolol in essential hypertension.
Why the study?
The effects of labetalol versus propranolol on peripheral circulation in hypertensive patients were not fully characterized, particularly regarding vascular resistance and blood pressure response to exercise.
Does labetalol improve peripheral circulation and lower blood pressure compared to propranolol in patients with essential hypertension?
RCT (n=11)
Double-blind
Does labetalol improve peripheral circulation and lower blood pressure compared to propranolol in patients with essential hypertension?
Effect estimate: 20% lower
p-value: p=<0.05
Labetalol lowers resting vascular resistance and basal vascular tone more effectively than propranolol in hypertensive patients, likely due to its alpha-receptor blocking action.
May support labetalol over propranolol for BP control; extends head-to-head crossover RCT data in essential hypertension.
Eleven patients with essential hypertension participated in a double-blind cross-over comparison of labetalol (L) and propranolol (P). Each drug was given for 5--8 weeks. The dose reducing the supine diastolic blood pressure when given b.d. to or below 90 mm Hg was titrated out. At the end of each period, isometric exercise (sustained handgrip) and calf plethysmography were performed. L (mean daily dose 636 mg) was slightly more effective in lowering supine and standing blood pressure than P (mean dose 276 mg). There was no significant difference between the drugs in their effect on the blood-pressure response to handgrip. However, compared with no treatment, L attenuated the blood-pressure rise at near-maximal handgrip; this has not been reported with other beta-blockers. Resting vascular resistance and basal vascular tone were significantly lower (20%, p less than 0.05) during treatment with labetalol than when the patients were taking propranolol. - The differences may be explained by the alpha-receptorblocking action of labetalol.
No takes yet. Share an insight, caveat, or question.
Nyberg et al. (1982) conducted an RCT in Essential hypertension (n=11). Labetalol vs. Propranolol (mean dose 276 mg) was evaluated on Resting vascular resistance and basal vascular tone (20% lower, p=<0.05). Labetalol significantly lowered resting vascular resistance and basal vascular tone by 20% compared to propranolol (p<0.05) in patients with essential hypertension.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: